AbbVie to buy Botox-maker Allergan in $63 billion deal
Share:
(Reuters) - AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc in a cash-and-stock deal for about $63 billion (49 billion pounds) to add fast-growing therapeutic businesses such as medical aesthetics and eye care.Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each share held, for a total consideration of $188.24 per Allergan share, a premium of 45% to Allergan's Monday close. The deal is expected to add 10% to adjusted earnings per share over the..